Summaries & Associations of Study Results
TR-060 Phenesterin
Target Organs and Levels of Evidence
NTP Technical Report Number 060
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| PHENESTERIN 3546-10-9 |
03/06/78 | ANTICANCER DRUG | Gavage R: 0,5,10, M: 0,15,30 MG/KG/15 PER GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NEGATIVE | ||||
| FR: POSITIVE | MAMMARY GLAND (ADENOCARCINOMA) | |||
| MM: POSITIVE | LUNG (ALVEOLAR/BRONCHIOLAR CARCINOMA) | |||
| HEMATOPOIETIC SYSTEM (LYMPHOMA) | ||||
| HEART (SARCOMA) | ||||
| FM: POSITIVE | LUNG (ALVEOLAR/BRONCHIOLAR CARCINOMA) | |||
| HEMATOPOIETIC SYSTEM (LYMPHOMA) | ||||
| HEART (SARCOMA) | ||||
Web page last updated on February 10, 2006
